These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15477707)

  • 1. Epidemiology of neuroendocrine tumours.
    Taal BG; Visser O
    Neuroendocrinology; 2004; 80 Suppl 1():3-7. PubMed ID: 15477707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
    Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
    Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.
    Pape UF; Berndt U; Müller-Nordhorn J; Böhmig M; Roll S; Koch M; Willich SN; Wiedenmann B
    Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
    Niederle MB; Hackl M; Kaserer K; Niederle B
    Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors.
    Kauffmann RM; Wang L; Phillips S; Idrees K; Merchant NB; Parikh AA
    Ann Surg Oncol; 2014 Oct; 21(11):3422-8. PubMed ID: 25059786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.
    Metz DC
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S153-9. PubMed ID: 10604121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract.
    Amarapurkar DN; Juneja MP; Patel ND; Amarapurkar AD; Amarapurkar PD
    Trop Gastroenterol; 2010; 31(2):101-4. PubMed ID: 20862983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut.
    Strosberg J; Gardner N; Kvols L
    Neuroendocrinology; 2009; 89(4):471-6. PubMed ID: 19174605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours.
    Lepage C; Bouvier AM; Faivre J
    Eur J Endocrinol; 2013 Apr; 168(4):R77-83. PubMed ID: 23349330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
    Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
    Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological implications in the neuroendocrine gastrointestinal system].
    Piette C; Polus M; Louis E
    Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroendocrine tumours of pancreas and gastrointestinal tract].
    Tsimmerman IaS
    Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.
    Modlin IM; Champaneria MC; Chan AK; Kidd M
    Am J Gastroenterol; 2007 Jul; 102(7):1464-73. PubMed ID: 17391319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
    Kamp K; Damhuis RA; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2012 Feb; 19(1):95-9. PubMed ID: 22194442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and emerging syndromes due to neuroendocrine tumors.
    Vinik AI; Gonzales MR
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):19-63, vii. PubMed ID: 21349410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of a nationwide survey of gastrointestinal tumors in Japan].
    Ito T; Tanaka M; Imamura M;
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):128-32. PubMed ID: 18536315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of intestinal carcinoids.
    Angeletti S; Annibale B; Marignani M; Corleto VD; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S108-10. PubMed ID: 10604113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry.
    Korse CM; Taal BG; van Velthuysen ML; Visser O
    Eur J Cancer; 2013 May; 49(8):1975-83. PubMed ID: 23352435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.